{
    "data": [
        {
            "id": "69a0609d24c37e0001bb5fa8",
            "title": "Laura Howell Implements A Sell Strategy: Offloads $1.13M In Akamai Technologies Stock",
            "description": "<div><div class=\"sc-gfrmXj kPLDLR\"><!--$--><p class=\"block core-block\"><strong>Laura Howell</strong>, SVP at <strong>Akamai Technologies</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/AKAM\" target=\"_blank\">AKAM</a>), reported an insider sell on February 25, according to a new SEC filing. </p><!--/$--><!--$--><p class=\"block core-block\"><strong>What Happened:</strong> Howell's recent move involves selling 11,273 shares of <strong>Akamai Technologies</strong>. This information is documented in a Form 4 filing with the <a href=\"https://www.sec.gov/Archives/edgar/data/0001086222/000186720326000006//Archives/edgar/data/1086222/000186720326000006/0001867203-26-000006-index.htm\" target=\"_blank\">U.S. Securities and Exchange Commission</a> on Wednesday. The total value is $1,128,822.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">In the Thursday's morning session, <strong>Akamai Technologies</strong>'s shares are currently trading at $99.58, experiencing a down of 1.29%.</p><!--/$--><!--$--><h3 class=\"block core-block\">Discovering Akamai Technologies: A Closer Look</h3><!--/$--><!--$--><p class=\"block core-block\">Akamai operates a content delivery network, which entails locating servers at the edges of networks so its customers, which store content on Akamai servers, can reach their own customers faster, more securely, and with better quality. Akamai has over 325,000 servers distributed over 4,100 points of presence in more than 1,000 cities worldwide. The firm also offers security and cloud computing for its customers, and those businesses have grown to be bigger than the legacy CDN.</p><!--/$--><!--$--><div class=\"sc-jHrKIi gTZsSs\"></div><!--/$--><!--$--><h3 class=\"block core-block\">Unraveling the Financial Story of Akamai Technologies</h3><!--/$--><!--$--><p class=\"block core-block\"><strong>Positive Revenue Trend:</strong> Examining Akamai Technologies's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>4.97%</strong> as of 30 September, 2025, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Information Technology sector.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Exploring Profitability:</strong></p><!--/$--><!--$?--><template id=\"B:2\"></template><div></div><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\"><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>1.11</strong>.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Navigating Market Valuation:</strong></p><!--/$--><!--$?--><template id=\"B:3\"></template><div></div><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\"><strong>Market Capitalization:</strong> Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.</p><!--/$--><!--$--><h3 class=\"block core-block\">The Relevance of Insider Transactions</h3><!--/$--><!--$--><p class=\"block core-block\">Insider transactions shouldn't be used primarily to make an investing decision, however an insider transaction can be an important factor in the investing decision. </p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$?--><template id=\"B:4\"></template><div></div><!--/$--><!--$--><p class=\"block core-block\">Pointing towards optimism, a company insider's new purchase signals their positive anticipation for the stock to rise.</p><!--/$--><!--$--><p class=\"block core-block\">Despite insider sells not always signaling a bearish sentiment, they can be driven by various factors.</p><!--/$--><!--$--><h3 class=\"block core-block\">Deciphering Transaction Codes in Insider Filings</h3><!--/$--><!--$?--><template id=\"B:5\"></template><div></div><!--/$--><!--$--><p class=\"block core-block\"><a href=\"https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001086222\" target=\"_blank\"><strong>Check Out The Full List Of Akamai Technologies's Insider Trades.</strong></a></p><!--/$--><!--$--><p class=\"block core-block\"><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/11/06/insider_trade_2.jpg",
            "link": "https://www.benzinga.com/insights/news/26/02/50891062/laura-howell-implements-a-sell-strategy-offloads-1-13m-in-akamai-technologies-stock",
            "pub_date": "2026-02-26 23:02:57",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69a0622c24c37e0001bb6196",
            "title": "Avalon GloboCare (ALBT) Stock Surges On AMD AI News",
            "description": "<div><div class=\"sc-gfrmXj kPLDLR\"><!--$--><p class=\"block core-block\">Shares of <strong>Avalon GloboCare Corp</strong> <a class=\"ticker-link\" data-exchange=\"NASDAQ\" data-ticker=\"ALBT\" href=\"https://www.benzinga.com/quote/ALBT\" rel=\"noopener\" target=\"_blank\">(NASDAQ:</a><a class=\"ticker\" href=\"https://www.benzinga.com/quote/ALBT\" target=\"_blank\">ALBT</a>)<!-- --> are trading sharply higher Thursday morning after Benzinga exclusively reported that the company joined <strong>Advanced Micro Devices Inc’s</strong> <a class=\"ticker-link\" data-exchange=\"NASDAQ\" data-ticker=\"AMD\" href=\"https://www.benzinga.com/quote/AMD\" rel=\"noopener\" target=\"_blank\">(NASDAQ:</a><a class=\"ticker\" href=\"https://www.benzinga.com/quote/AMD\" target=\"_blank\">AMD</a>)<!-- --> AI Developer Program. </p><!--/$--><!--$--><p class=\"block core-block\">Here’s what investors <a href=\"https://www.benzinga.com/markets/small-cap/26/02/50884774/exclusive-avalon-globocare-partners-with-amd-to-supercharge-ai\" target=\"_blank\">need to know</a>.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li>Avalon Globocare stock is charging ahead with explosive momentum. <a href=\"https://www.benzinga.com/quote/ALBT\" rel=\"noreferrer noopener\" target=\"_blank\">Why is ALBT stock up today?</a></li>\n</ul><!--/$--><!--$--><h2 class=\"wp-block-heading\">Avalon Quantum AI Joins AMD</h2><!--/$--><!--$--><p class=\"block core-block\">In the release, the Freehold, N.J.-based company said its AI-focused subsidiary,<strong> Avalon Quantum AI LLC</strong>, has been accepted into the AMD AI Developer Program, giving it access to AMD Developer Cloud credits, development tools, training and community resources, plus high-performance computing powered by AMD Instinct accelerators and EPYC processors. </p><!--/$--><!--$--><div class=\"sc-jHrKIi gTZsSs\"></div><!--/$--><!--$--><p class=\"block core-block\">Avalon <a href=\"https://www.benzinga.com/pressreleases/26/02/g50886038/avalon-globocares-subsidiary-accepted-into-amd-ai-developer-program-to-advance-next-generation-med\" target=\"_blank\">plans to leverage</a> those resources to scale its automated commentary video engine, enterprise documentation tools and an AI-powered workflow automation platform.</p><!--/$--><!--$--><h2 class=\"wp-block-heading\">Avalon Advances AI, KetoAir Strategy</h2><!--/$--><!--$--><p class=\"block core-block\">Interim CEO and COO <strong>Meng Li</strong> <a href=\"https://www.benzinga.com/markets/small-cap/26/02/50884774/exclusive-avalon-globocare-partners-with-amd-to-supercharge-ai\" target=\"_blank\">said</a> the program reinforces Avalon’s repositioning as a technology-focused AI company and positions AQAI as a core growth driver in automated media production and enterprise AI applications.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">Avalon is also advancing KetoAir, a handheld breathalyzer designed for ketogenic health management that recently renewed its establishment registration with the U.S. Food and Drug Administration. </p><!--/$--><!--$--><p class=\"block core-block\">Avalon says the device, which connects to iOS and Android apps, is expected to enter broader business-to-business and direct-to-consumer marketing in the second quarter of 2026, with AQAI helping drive data-driven marketing and distribution.</p><!--/$--><!--$--><h2 class=\"wp-block-heading\">ALBT Shares Surge Over 100% Thursday</h2><!--/$--><!--$--><p class=\"block core-block\"><strong>ALBT Price Action:</strong> Avalon Globocare shares were up 96.42% at $1.00 at the time of publication on Thursday, <a href=\"https://www.benzinga.com/pro/\" rel=\"noreferrer noopener\" target=\"_blank\">according to Benzinga Pro data</a>.</p><!--/$--><!--$--><p class=\"block core-block\"><em>Image: Shutterstock</em></p><!--/$--><!--$--><div class=\"bz-optimizely-campaign bz-optimizely-campaign-bottom-50891533\" data-nosnippet=\"true\"></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2026/02/26/Richmond--Virginia--Usa---9-May-2019-Ill_0.jpeg",
            "link": "https://www.benzinga.com/trading-ideas/movers/26/02/50891533/avalon-globocare-albt-stock-surges-on-amd-ai-news",
            "pub_date": "2026-02-26 23:09:26",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69a05ea124c37e0001bb5cdd",
            "title": "PENN Surges 10% On Q4 Double Beat, Record Interactive Segment Performance",
            "description": "<div><div class=\"sc-gfrmXj kPLDLR\"><!--$--><p class=\"block core-block\"><strong>PENN Entertainment, Inc. </strong><a class=\"ticker-link\" data-exchange=\"NASDAQ\" data-ticker=\"PENN\" href=\"https://www.benzinga.com/quote/PENN\" rel=\"noopener\" target=\"_blank\">(NASDAQ:</a><a class=\"ticker\" href=\"https://www.benzinga.com/quote/PENN\" target=\"_blank\">PENN</a>)<!-- --> shares are trading higher Thursday after the company reported fourth-quarter financial results.</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li>Penn stock is surging to new heights today. <a href=\"https://www.benzinga.com/quote/PENN\" rel=\"noreferrer noopener\" target=\"_blank\">What’s fueling PENN momentum?</a></li>\n</ul><!--/$--><!--$--><h2 class=\"wp-block-heading\"><strong>Beat On EPS, Revenue As Interactive Segment Gains Traction</strong></h2><!--/$--><!--$--><p class=\"block core-block\">The company reported adjusted earnings per share of 7 cents, beating the consensus estimate of a 5-cent loss. Revenue totaled $1.80 billion, exceeding the consensus estimate of $1.76 billion.</p><!--/$--><!--$--><p class=\"block core-block\">Retail segment revenue was $1.4 billion in the fourth-quarter. The Interactive segment generated revenue of $398.7 million.</p><!--/$--><!--$--><p class=\"block core-block\">\"We experienced record Interactive segment gaming revenue in the fourth quarter driven by the continued growth of our standalone Hollywood iCasino product and increased cross-sell, as well as improvements in our online sportsbook product offering and operations,\" said CEO<strong> Jay Snowden</strong>.</p><!--/$--><!--$--><p class=\"block core-block\">As of Dec. 31, total liquidity was $1.1 billion, including $686.6 million in cash and cash equivalents. Traditional net debt stood at $2.2 billion at quarter end.</p><!--/$--><!--$--><h2 class=\"wp-block-heading\">Penn Stock Climbs Higher</h2><!--/$--><!--$--><p class=\"block core-block\"><strong>PENN Price Action:</strong> At the time of publication, Penn shares are trading 10.45% higher at $13.85, according to data from <a href=\"https://pro.benzinga.com/dashboard\" target=\"_blank\">Benzinga Pro</a>.</p><!--/$--><!--$--><p class=\"block core-block\"><em>This illustration was generated using artificial intelligence via Midjourney.</em></p><!--/$--><!--$--><div class=\"bz-optimizely-campaign bz-optimizely-campaign-middle-50890394\" data-nosnippet=\"true\"></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2026/02/26/benzingaai2023-stock-market-trading-setu.png",
            "link": "https://www.benzinga.com/trading-ideas/movers/26/02/50890394/penn-surges-10-on-q4-double-beat-record-interactive-segment-performance",
            "pub_date": "2026-02-26 22:54:28",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69a05d9124c37e0001bb5bb0",
            "title": "AtaiBeckley Touts Social Anxiety Breakthrough With Phase 2 Trial Data",
            "description": "<div><div class=\"sc-gfrmXj kPLDLR\"><!--$--><p class=\"block core-block\"><strong>AtaiBeckley Inc.</strong> <a class=\"ticker-link\" data-exchange=\"NASDAQ\" data-ticker=\"ATAI\" href=\"https://www.benzinga.com/quote/ATAI\" rel=\"noopener\" target=\"_blank\">(NASDAQ:</a><a class=\"ticker\" href=\"https://www.benzinga.com/quote/ATAI\" target=\"_blank\">ATAI</a>)<!-- --> on Thursday shared topline results from an exploratory Phase 2a trial of EMP-01, an oral R-MDMA treatment for Social Anxiety Disorder.</p><!--/$--><!--$--><p class=\"block core-block\">The encouraging data highlights a favorable safety profile and significant patient improvement, which may be contributing to the stock’s upward movement <a href=\"https://www.benzinga.com/pressreleases/26/02/g50881728/ataibeckley-announces-positive-topline-results-from-an-exploratory-phase-2a-trial-of-emp-01-oral-r\" rel=\"noreferrer noopener\" target=\"_blank\">from an exploratory Phase</a>.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">Social Anxiety Data</h2><!--/$--><!--$--><p class=\"block core-block\">In the trial, 49% of patients receiving EMP-01 were rated as “very much improved” or “much improved,” compared to only 15% in the placebo group, indicating a clinically meaningful improvement.</p><!--/$--><!--$--><p class=\"block core-block\">The 34-percentage-point difference corresponds to a Number Needed to Treat (NNT) of 2.95, indicating a clinically meaningful level of global improvement in the EMP-01 group.</p><!--/$--><!--$--><div class=\"sc-jHrKIi gTZsSs\"></div><!--/$--><!--$--><p class=\"block core-block\">EMP-01 demonstrated improvements across both Fear and Avoidance sub-domains of the Liebowitz Social Anxiety Scale (LSAS), including improvement in social avoidance behaviors after two administrations over six weeks, and without adjunctive psychotherapy.</p><!--/$--><!--$--><p class=\"block core-block\">The study, which involved 71 adults across seven clinical sites in the U.K., met its primary safety objective, showing no serious adverse events.</p><!--/$--><!--$--><p class=\"block core-block\">The results suggest that EMP-01 could significantly impact the treatment landscape for Social Anxiety Disorder, a condition that has seen little therapeutic advancement in over two decades.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">Technical Analysis</h2><!--/$--><!--$--><p class=\"block core-block\">The stock is currently trading 10.5% below its 20-day simple moving average (SMA) and 5.2% below its 100-day SMA, indicating some short-term weakness. Over the past 12 months, shares have increased by 43%, and they are currently positioned closer to their 52-week highs than lows, reflecting a strong longer-term trend.</p><!--/$--><!--$--><p class=\"block core-block\">The RSI is at 50.00, which is considered neutral territory, suggesting that the stock is neither overbought nor oversold. Meanwhile, MACD is at 0.10, below its signal line at 0.15, indicating bearish pressure on the stock.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">The combination of neutral RSI and bearish MACD suggests mixed momentum, indicating that traders should watch for potential changes in direction.</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong>Key Resistance</strong>: $5.00</li>\n<li><strong>Key Support</strong>: $4.00</li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><strong>ATAI Price Action:</strong> AtaiBeckley shares were down 10.60% at $3.88 at the time of publication on Thursday, <a href=\"https://www.benzinga.com/pro/\" rel=\"noreferrer noopener\" target=\"_blank\">according to Benzinga Pro data</a>.</p><!--/$--><!--$--><p class=\"block core-block\"><em>Image via Shutterstock/ fizkes</em></p><!--/$--><!--$--><div class=\"bz-optimizely-campaign bz-optimizely-campaign-bottom-50890103\" data-nosnippet=\"true\"></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2026/02/26/Sellers-Flood-Market-Amid-Anxiety.jpeg",
            "link": "https://www.benzinga.com/news/health-care/26/02/50890103/ataibeckley-touts-social-anxiety-breakthrough-with-phase-2-trial-data",
            "pub_date": "2026-02-26 22:49:56",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69a05dd524c37e0001bb5c08",
            "title": "Cass Information Systems Expands Tariff Management With AI Partner",
            "description": "<div><div class=\"sc-gfrmXj kPLDLR\"><!--$--><p class=\"block core-block\">On Thursday,<strong> Cass Information Systems, Inc.</strong> <a href=\"https://www.benzinga.com/quote/CASS\" rel=\"noreferrer noopener\" target=\"_blank\"></a><a class=\"ticker-link\" data-exchange=\"NASDAQ\" data-ticker=\"CASS\" href=\"https://www.benzinga.com/quote/CASS\" rel=\"noopener\" target=\"_blank\">(NASDAQ:</a><a class=\"ticker\" href=\"https://www.benzinga.com/quote/CASS\" target=\"_blank\">CASS</a>)<!-- --> announced a <a href=\"https://www.benzinga.com/pressreleases/26/02/b50883505/cass-information-systems-and-caspian-partner-to-deliver-comprehensive-tariff-cost-management-solut\" rel=\"noreferrer noopener\" target=\"_blank\">strategic partnership</a> with<strong> Caspian</strong>, an AI-powered customs refund platform, to introduce a comprehensive tariff cost management solution aimed at U.S. importers.</p><!--/$--><!--$--><p class=\"block core-block\">The collaboration is designed to improve cash flow, enhance compliance, and provide clearer insight into true landed product costs amid rising global trade complexity.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">Cass and Caspian’s Strategic Partnership</h2><!--/$--><!--$--><p class=\"block core-block\">The Cass–Caspian partnership will deliver a connected solution that combines payment processing, audit, compliance, recovery and reporting capabilities.</p><!--/$--><!--$--><p class=\"block core-block\">Caspian will enhance Cass’s existing payment and reporting infrastructure with AI-driven Harmonized Tariff Schedule modeling, advanced tariff audit tools, refund identification and full support for post summary corrections, protests and duty drawback programs.</p><!--/$--><!--$--><div class=\"sc-jHrKIi gTZsSs\"></div><!--/$--><!--$--><p class=\"block core-block\">Cass said clients leveraging its established ocean audit capabilities alongside the new tariff solution will gain more effective control over global trade costs.</p><!--/$--><!--$--><p class=\"block core-block\">This partnership strengthens our ability to help importers manage tariff costs with greater accuracy and transparency,” said <strong>Tony Urban</strong>, president of Cass’s freight payment organization. “Cass has supported duty payments for years. Now by adding Caspian’s compliance, audit, and recovery capabilities, we’re able to deliver the comprehensive solution our clients have been asking for.”</p><!--/$--><!--$--><h2 class=\"wp-block-heading\">Technical Analysis</h2><!--/$--><!--$--><p class=\"block core-block\">The stock is currently trading 9.8% below its 20-day simple moving average (SMA) and 4.1% below its 100-day SMA, indicating some short-term weakness. Shares have increased 24.5% over the past 12 months and are currently positioned closer to their 52-week highs than lows.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">The RSI is at 50.00, which is considered neutral territory, suggesting that the stock is neither overbought nor oversold. Meanwhile, MACD is at 0.15, below its signal line at 0.22, indicating bearish pressure on the stock.</p><!--/$--><!--$--><p class=\"block core-block\">The combination of neutral RSI and bearish MACD suggests mixed momentum.</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong>Key Resistance</strong>: $47.00</li>\n<li><strong>Key Support</strong>: $44.00</li>\n</ul><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">Next Financial Update</h2><!--/$--><!--$--><p class=\"block core-block\">CASS is slated to provide its next financial update on April 16, 2026.</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong>EPS Estimate</strong>: 62 cents (Down from 66 cents)</li>\n<li><strong>Revenue Estimate</strong>: $49.40 million (Up from $46.41 million)</li>\n<li><strong>Valuation</strong>: P/E of 19.4x (Indicates fair valuation)</li>\n</ul><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\"><strong>Analyst Consensus &amp; Recent Actions:</strong> The stock carries a Strong Buy rating with an <a href=\"https://www.benzinga.com/quote/NASDAQ:CASS/analyst-ratings\" rel=\"noreferrer noopener\" target=\"_blank\">average price target</a> of $45.50. Recent analyst moves include:</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong>Raymond James</strong>: Outperform (Lowers Target to $45.00) (Oct. 24, 2025)</li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><strong>CASS Price Action:</strong> Cass Information shares were trading up 1.20% at $44.87 at the time of publication on Thursday, <a href=\"https://www.benzinga.com/pro/\" rel=\"noreferrer noopener\" target=\"_blank\">according to Benzinga Pro data</a>.</p><!--/$--><!--$--><p class=\"block core-block\"><em>Photo via Shutterstock</em></p><!--/$--><!--$--><div class=\"bz-optimizely-campaign bz-optimizely-campaign-bottom-50890190\" data-nosnippet=\"true\"></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2026/02/26/MA-Businessman-Handshake.jpeg",
            "link": "https://www.benzinga.com/markets/equities/26/02/50890190/cass-information-systems-expands-tariff-management-with-ai-partner",
            "pub_date": "2026-02-26 22:51:04",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        }
    ]
}